Stress management for breast and gynecologic cancer patients in Vietnam
Official title: A Pilot Randomized Controlled Trial of Self-Help Plus Stress Management Intervention Among Breast and Gynecologic Cancer Patients in Viet Nam
Run by Boston University · NCT06398067 · Data updated 2026-11-12
This study tests a new stress management program for breast and gynecologic cancer patients in Vietnam to see if it can help them feel better emotionally compared to standard care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 285 (estimated) |
| Sponsor | Boston University Academic / other |
| Locations | 6 sites (Can Tho and 5 other locations) |
| Status | Recruiting |
| Started | November 5, 2024 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | November 17, 2025 |
| Trial ID | NCT06398067 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with a recent diagnosis of breast or gynecologic cancer who are currently receiving treatment with curative intent.
✕Probably not a fit
Patients with severe chronic diseases or those at imminent risk of suicide may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial evaluates the Vietnamese Self Help Plus (vSH+) stress management intervention among breast and gynecologic cancer patients in Vietnam. It is a randomized controlled trial where participants are assigned to either the vSH+ intervention or enhanced usual care. The study aims to address the psychological distress often experienced by cancer patients, which is frequently overlooked in clinical settings. Participants will receive an in-person informational session tailored to their assigned study arm, where informed consent will be obtained.
Why it matters
Potential benefit: If successful, this intervention could significantly improve the mental health and well-being of cancer patients in Vietnam.
How similar studies have gone: Other studies have shown success with similar stress management interventions, indicating potential for positive outcomes in this context.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged 18 years or older * Have a clinician-confirmed diagnosis within the past 12 months of first-time breast and/or gynecologic cancer (e.g., cervical, ovarian, uterine, vaginal, vulvar) in stages I-III * Currently or will receive treatment with curative intent * Score less than 8 on the National Comprehensive Cancer Network (NCCN) Distress Thermometer, indicating low to moderate levels of distress * Score less than 15 on the Patient Health Questionnaire-9 items (PHQ-9, indicating low to moderate levels of depression Exclusion Criteria: * Selected '2 Several days' or '3 Almost everyday' on PHQ9 item #9, indicating indicating imminent risk of suicide * Have severe chronic diseases (e.g., coronary heart disease, chronic obstructive pulmonary disease (COPD), chronic renal failure), at the discretion of the treating clinician or study investigator * People with a risk for psychosis, mania, and alcohol abuse, based on screening questions commonly used in the field * Cannot attend the intervention activities at the hospital during the proposed intervention period
Where it's running
-
Can Tho Oncology Hospital
Can Tho, Vietnam Recruiting -
Oncology Center, Cho Ray Hospital
Chợ Rây, Vietnam Recruiting -
Da Nang Oncology Hospital
Da Nang, Vietnam Recruiting -
Breast and Gynecology Department, Hung Vuong Women's Hospital
Ho Chi Minh City, Vietnam Recruiting -
Ho Chi Minh City Oncology Hospital
Ho Chi Minh City, Vietnam Recruiting -
Oncology Center, Hue Central Hospital
Huế, Vietnam Recruiting
Study contacts
- Principal investigator: Phuongthao Le, PhD — Boston University
- Study coordinator: Phuongthao Le, PhD
- Email: ptle@bu.edu
- Phone: 617 358 1342
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Personalized supervised exercise program for adults with breast or gynecologic cancer
A small pilot study will test a supervised, personalized exercise program to see if it is safe, feasible, and acceptable for adults with a history of breast or gynecologic cancer.
-
High-precision detection of leftover cancer using a liquid-biopsy platform (SHERLOCK)
This project will test whether sensitive blood and other fluid tests for circulating tumor DNA can find leftover cancer (minimal residual disease) in adults treated with curative intent for breast, lung, melanoma, gynecologic, or genitourinary cancers.
-
Riluzole to prevent thinking and memory problems during chemotherapy
This pilot trial tests whether riluzole can prevent thinking and memory problems in adults with cancer receiving anthracycline- or platinum-based chemotherapy.
-
Web app for reporting side effects during radiation therapy
This project will try a web app that lets people receiving radiation for breast, gynecologic, or urologic cancers report symptoms and quality of life so clinicians can spot problems earlier.
-
7-day Via Shalva integrative retreat for breast and gynecologic cancer survivors
This pilot will try a 7-day integrative retreat called Via Shalva for breast and gynecologic cancer survivors to see if the program is feasible and whether participants show changes in symptoms, wearable physiological data, and biological markers versus matched controls.
-
Guided meditation during radiation for breast and gynecologic cancers
This project will test whether short guided meditations played during daily radiation can reduce anxiety for adults receiving radiation for breast or gynecologic cancer.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.